Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer.

Klupczynska A, Swiatly A, Hajduk J, Matysiak J, Dyszkiewicz W, Pawlak K, Kokot ZJ.

Int J Mol Sci. 2016 Mar 31;17(4):410. doi: 10.3390/ijms17040410.

2.

Influence of honeybee sting on peptidome profile in human serum.

Matysiak J, Światły A, Hajduk J, Matysiak J, Kokot ZJ.

Toxins (Basel). 2015 May 22;7(5):1808-20. doi: 10.3390/toxins7051808.

3.

Accessing to the minor proteome of red blood cells through the influence of the nanoparticle surface properties on the corona composition.

Zaccaria A, Roux-Dalvai F, Bouamrani A, Mombrun A, Mossuz P, Monsarrat B, Berger F.

Int J Nanomedicine. 2015 Mar 9;10:1869-83. doi: 10.2147/IJN.S70503. eCollection 2015.

4.

Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies.

Timms JF, Arslan-Low E, Kabir M, Worthington J, Camuzeaux S, Sinclair J, Szaub J, Afrough B, Podust VN, Fourkala EO, Cubizolles M, Kronenberg F, Fung ET, Gentry-Maharaj A, Menon U, Jacobs I.

Proteomics Clin Appl. 2014 Dec;8(11-12):982-93. doi: 10.1002/prca.201400063. Epub 2014 Nov 10.

5.

Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer.

Nazarian A, Lawlor K, Yi SS, Philip J, Ghosh M, Yaneva M, Villanueva J, Saghatelian A, Assel M, Vickers AJ, Eastham JA, Scher HI, Carver BS, Lilja H, Tempst P.

Mol Cell Proteomics. 2014 Nov;13(11):3082-96. doi: 10.1074/mcp.M114.038836. Epub 2014 Jul 23.

6.

Identification of potential serum peptide biomarkers of biliary tract cancer using MALDI MS profiling.

Sandanayake NS, Camuzeaux S, Sinclair J, Blyuss O, Andreola F, Chapman MH, Webster GJ, Smith RC, Timms JF, Pereira SP.

BMC Clin Pathol. 2014 Feb 4;14(1):7. doi: 10.1186/1472-6890-14-7.

7.

Quantitative trait loci mapping of the mouse plasma proteome (pQTL).

Holdt LM, von Delft A, Nicolaou A, Baumann S, Kostrzewa M, Thiery J, Teupser D.

Genetics. 2013 Feb;193(2):601-8. doi: 10.1534/genetics.112.143354. Epub 2012 Nov 19.

8.

Profiling plasma peptides for the identification of potential ageing biomarkers in Chinese Han adults.

Lu J, Huang Y, Wang Y, Li Y, Zhang Y, Wu J, Zhao F, Meng S, Yu X, Ma Q, Song M, Chang N, Bittles AH, Wang W.

PLoS One. 2012;7(7):e39726. doi: 10.1371/journal.pone.0039726. Epub 2012 Jul 3.

9.

A high performance profile-biomarker diagnosis for mass spectral profiles.

Han H.

BMC Syst Biol. 2011;5 Suppl 2:S5. doi: 10.1186/1752-0509-5-S2-S5. Epub 2011 Dec 14.

10.

MS/MS library facilitated MRM quantification of native peptides prepared by denaturing ultrafiltration.

Lenco J, Lan R, Edwards N, Goldman R.

Proteome Sci. 2012 Feb 4;10(1):7. doi: 10.1186/1477-5956-10-7.

11.

Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays.

Cohen M, Yossef R, Erez T, Kugel A, Welt M, Karpasas MM, Bones J, Rudd PM, Taieb J, Boissin H, Harats D, Noy K, Tekoah Y, Lichtenstein RG, Rubin E, Porgador A.

PLoS One. 2011 Jan 18;6(1):e14540. doi: 10.1371/journal.pone.0014540.

12.

Perspectives of targeted mass spectrometry for protein biomarker verification.

Hüttenhain R, Malmström J, Picotti P, Aebersold R.

Curr Opin Chem Biol. 2009 Dec;13(5-6):518-25. doi: 10.1016/j.cbpa.2009.09.014. Epub 2009 Oct 7. Review.

13.

Monitoring peptidase activities in complex proteomes by MALDI-TOF mass spectrometry.

Villanueva J, Nazarian A, Lawlor K, Tempst P.

Nat Protoc. 2009;4(8):1167-83. doi: 10.1038/nprot.2009.88. Epub 2009 Jul 23.

Supplemental Content

Support Center